 Docosahexaenoic Acids
"Docosahexaenoic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
C22-unsaturated fatty acids found predominantly in FISH OILS.
| Descriptor ID |
D004281
|
| MeSH Number(s) |
D10.212.302.380.410.210 D10.251.355.337.250 D10.627.430.450.375
|
| Concept/Terms |
Docosahexaenoic Acids- Docosahexaenoic Acids
- Acids, Docosahexaenoic
- Docosahexenoic Acids
- Acids, Docosahexenoic
Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer- Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer
Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)- Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)
Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt- Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt
Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt- Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt
Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)- Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)
Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer- Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer
Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt- Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt
Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt- Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt
|
Below are MeSH descriptors whose meaning is more general than "Docosahexaenoic Acids".
Below are MeSH descriptors whose meaning is more specific than "Docosahexaenoic Acids".
This graph shows the total number of publications written about "Docosahexaenoic Acids" by people in this website by year, and whether "Docosahexaenoic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 1 | 3 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 1 | 3 | | 2017 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Docosahexaenoic Acids" by people in Profiles.
-
Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Lundström T, Agrawal R, Menon V, Wolski K, Nissen SE. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA. 2020 12 08; 324(22):2268-2280.
-
Dunbar RL, Gaudet D, Davidson M, Rensfeldt M, Yang H, Nilsson C, Kvarnström M, Oscarsson J. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids Health Dis. 2020 May 30; 19(1):117.
-
Lock JY, Carlson TL, Yu Y, Lu J, Claud EC, Carrier RL. Impact of Developmental Age, Necrotizing Enterocolitis Associated Stress, and Oral Therapeutic Intervention on Mucus Barrier Properties. Sci Rep. 2020 04 21; 10(1):6692.
-
Frost BL, Caplan MS. Can Fish Oil Reduce the Incidence of Necrotizing Enterocolitis by Altering the Inflammatory Response? Clin Perinatol. 2019 03; 46(1):65-75.
-
Offman E, Davidson M, Abu-Rashid M, Chai P, Nilsson C. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers. Eur J Drug Metab Pharmacokinet. 2017 Oct; 42(5):815-825.
-
Basak S, Schmandt N, Gicheru Y, Chakrapani S. Crystal structure and dynamics of a lipid-induced potential desensitized-state of a pentameric ligand-gated channel. Elife. 2017 03 06; 6.
-
Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. J Clin Lipidol. 2016 Nov - Dec; 10(6):1442-1451.e4.
-
Robinson DT, Caplan M, Carlson SE, Yoder R, Murthy K, Frost B. Early docosahexaenoic and arachidonic acid supplementation in extremely-low-birth-weight infants. Pediatr Res. 2016 10; 80(4):505-10.
-
Subbaiah PV, Dammanahalli KJ, Yang P, Bi J, O'Donnell JM. Enhanced incorporation of dietary DHA into lymph phospholipids by altering its molecular carrier. Biochim Biophys Acta. 2016 Aug; 1861(8 Pt A):723-9.
-
Dunbar RL, Nicholls SJ, Maki KC, Roth EM, Orloff DG, Curcio D, Johnson J, Kling D, Davidson MH. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Lipids Health Dis. 2015 Sep 02; 14:98.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|